Abridge nabbed a $300 million Series E led by a16z, months after it closed its previous $250 million fundraise. The 7-year-old Abridge is widely considered to be the leader in the increasingly crowded AI-powered medical scribe market, largely due to its early entry and integration with Epic Systems, the dominant health record software.
Abridge nabbed a $300 million Series E led by a16z, months after it closed its previous $250 million fundraise. The 7-year-old Abridge is widely considered to be the leader in the increasingly crowded AI-powered medical scribe market, largely due to its early entry and integration with Epic Systems, the dominant health record software.
Leave a comment